Applying CyTOF solutions to cancer immunotherapy clinical trials
28 Jul 2025It is critical for immunotherapy clinical trials to have an in-depth picture of the immune response to disease and to therapeutic treatments to better identify predictive markers, biomarker translation and understanding mechanism of action.
Explore how CyTOF™ – a single-cell proteomics platform from Standard BioTools – can capture relevant immune metrics and highly multiplexed surface and functional markers simultaneously, to uncover unique biomarkers.
Related Products
Request Quote for All Products
CyTOF® XT
Standard BioTools Inc.The next-generation mass cytometer, CyTOF XT™, redefines high-parameter cytometry with advances in automation, throughput, time to results and total cost of ownership. Built to simplify the design and execution of deep cell profiling studies, CyTOF XT standardizes sample analysis with reproducible workflows and automation to accelerate novel therapeutic development and improve human health.